BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 23911772)

  • 1. Multivariate analysis based on the maximum standard unit value of
    Wang Y; Lyu D; Zhou T; Tu W; Fan L; Liu S
    Diagn Interv Radiol; 2023 Mar; 29(2):379-389. PubMed ID: 36988049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic thresholds of fluorine-18 fluorodeoxyglucose-positron emission tomography mean and maximum standardized uptake values for survival and nodal involvement in lung neuroendocrine neoplasms.
    Soldath P; Binderup T; Kjaer A; Knigge U; Langer SW; Petersen RH
    Eur J Cardiothorac Surg; 2024 Feb; 65(2):. PubMed ID: 38305412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy.
    Ikenaga N; Nakata K; Hayashi M; Nakamura S; Abe T; Ideno N; Murakami M; Fujimori N; Fujita N; Isoda T; Baba S; Ishigami K; Oda Y; Nakamura M
    J Gastrointest Surg; 2023 Feb; 27(2):337-346. PubMed ID: 36652179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between Radiological Characteristics, PET-CT and Histological Subtypes of Primary Lung Adenocarcinoma-A 102 Case Series Analysis.
    Colic N; Stevic R; Stjepanovic M; Savić M; Jankovic J; Belic S; Petrovic J; Bogosavljevic N; Aleksandric D; Lukic K; Kostić M; Saponjski D; Vasic Madzarevic J; Stojkovic S; Ercegovac M; Garabinovic Z
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674262
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of OTL38-Generated Tumor-to-Background Ratio in Intraoperative Molecular Imaging-Guided Lung Cancer Resections.
    Azari F; Kennedy G; Bernstein E; Delikatny J; Lee JYK; Kucharczuk J; Low PS; Singhal S
    Mol Imaging Biol; 2023 Feb; 25(1):85-96. PubMed ID: 34101106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleural Carcinoembryonic Antigen and Maximum Standardized Uptake Value as Predictive Indicators of Visceral Pleural Invasion in Clinical T1N0M0 Lung Adenocarcinoma.
    Na HR; Moon SW; Kim KS; Moon MH; Hyun K; Yoon SK
    J Chest Surg; 2024 Jan; 57(1):44-52. PubMed ID: 38174890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Uptake of Jejunal Lymphocytosis Due to Giardiasis Mimicking Lymphoma Recurrence.
    Kamaleshwaran KK; Elumalai R; Rangarajan B
    Indian J Nucl Med; 2024; 39(1):59-60. PubMed ID: 38817729
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of CD47 Blockade on Vascular Inflammation.
    Jarr KU; Nakamoto R; Doan BH; Kojima Y; Weissman IL; Advani RH; Iagaru A; Leeper NJ
    N Engl J Med; 2021 Jan; 384(4):382-383. PubMed ID: 33503349
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased
    Lee D; Yun T; Koo Y; Chae Y; Kim H; Yang MP; Lee S; Kang BT
    J Small Anim Pract; 2023 Nov; 64(11):727. PubMed ID: 37491743
    [No Abstract]   [Full Text] [Related]  

  • 10. CME instructions: Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation.
    J Nucl Cardiol; 2017 Feb; 24(1):83-85. PubMed ID: 28108928
    [No Abstract]   [Full Text] [Related]  

  • 11. Correction: Maximum standardized uptake value in 
    Kuroshima T; Kitagawa Y; Sato J; Watanabe S; Asaka T; Abe T; Harada H; Hirata K; Kuge Y
    Odontology; 2024 May; ():. PubMed ID: 38767723
    [No Abstract]   [Full Text] [Related]  

  • 12. Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer.
    Morimoto H; Hida Y; Maishi N; Nishihara H; Hatanaka Y; Li C; Matsuno Y; Nakamura T; Hirano S; Hida K
    Thorac Cancer; 2021 May; 12(9):1347-1357. PubMed ID: 33709550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Looking for Lepidic Component inside Invasive Adenocarcinomas Appearing as CT Solid Solitary Pulmonary Nodules (SPNs): CT Morpho-Densitometric Features and 18-FDG PET Findings.
    Reginelli A; Capasso R; Petrillo M; Rossi C; Faella P; Grassi R; Belfiore MP; Rossi G; Muto M; Muto P; Fiorello A; Serra N; Nizzoli R; De Filippo M; Cappabianca S; Carrafiello G; Brunese L; Rotondo A
    Biomed Res Int; 2019; 2019():7683648. PubMed ID: 30733967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial lung disease pattern turned out to be a predominantly lepidic lung adenocarcinoma.
    Hammen I
    Respir Med Case Rep; 2017; 21():56-58. PubMed ID: 28393007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS).
    Tang ER; Schreiner AM; Pua BB
    J Thorac Dis; 2014 Oct; 6(Suppl 5):S489-501. PubMed ID: 25349701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathologic characterization of lung adenocarcinoma in relation to fluorine-18-fluorodeoxyglucose uptake on positron emission tomography.
    Domen H; Hida Y; Okamoto S; Hatanaka KC; Hatanaka Y; Kaga K; Tamaki N; Hirano S; Matsuno Y
    Jpn J Clin Oncol; 2013 Sep; 43(9):874-82. PubMed ID: 23911772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in prognostic significance of maximum standardized uptake value on [18F]-fluoro-2-deoxyglucose positron emission tomography between adenocarcinoma and squamous cell carcinoma of the lung.
    Tsutani Y; Miyata Y; Misumi K; Ikeda T; Mimura T; Hihara J; Okada M
    Jpn J Clin Oncol; 2011 Jul; 41(7):890-6. PubMed ID: 21613306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas.
    Okada M; Tauchi S; Iwanaga K; Mimura T; Kitamura Y; Watanabe H; Adachi S; Sakuma T; Ohbayashi C
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1448-54. PubMed ID: 17532938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer.
    Furukawa T; Miyata Y; Kushitani K; Mimae T; Tsutani Y; Takeshima Y; Okada M
    Jpn J Clin Oncol; 2015 Dec; 45(12):1154-61. PubMed ID: 26386467
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.